2015
Tools of the Trade: Adjunctive Tools for Lesion Crossing in Critical Limb Ischemia
Goldsweig A, Hasan F, Mena C. Tools of the Trade: Adjunctive Tools for Lesion Crossing in Critical Limb Ischemia. Medical Equipment Insights 2015, 6: mei.s18479. DOI: 10.4137/mei.s18479.Peer-Reviewed Original ResearchCritical limb ischemiaTrue lumenReentry deviceLimb ischemiaLesion crossingAtherectomy devicesAdjunctive toolChronic total occlusionDistal true lumenLives of patientsMechanical atherectomy devicesCrossing deviceTotal occlusionMechanical atherectomyOrbital atherectomyLaser atherectomyFurther interventionCause painTissue damageAtherectomyVessel lumenIschemiaAtheroma
2014
Randomized Controlled Study of Excimer Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis Initial Results From the EXCITE ISR Trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis)
Dippel EJ, Makam P, Kovach R, George JC, Patlola R, Metzger DC, Mena-Hurtado C, Beasley R, Soukas P, Colon-Hernandez PJ, Stark MA, Walker C, Investigators E. Randomized Controlled Study of Excimer Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis Initial Results From the EXCITE ISR Trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovascular Interventions 2014, 8: 92-101. PMID: 25499305, DOI: 10.1016/j.jcin.2014.09.009.Peer-Reviewed Original ResearchMeSH KeywordsAgedAlloysAmputation, SurgicalAngioplasty, BalloonAtherectomyChronic DiseaseCombined Modality TherapyConstriction, PathologicFemaleFemoral ArteryHumansLaser TherapyLasers, ExcimerLimb SalvageMaleMiddle AgedPeripheral Arterial DiseasePopliteal ArteryProspective StudiesProsthesis DesignRecurrenceStentsTime FactorsTreatment OutcomeUnited StatesVascular PatencyConceptsPercutaneous transluminal angioplastyTarget lesion revascularizationExcimer laser atherectomyLaser atherectomyAdjunctive percutaneous transluminal angioplastyMajor adverse event rateChronic peripheral artery diseaseLesion lengthLifestyle-limiting claudicationPrimary safety endpointRutherford class 1Target lesion lengthPrimary efficacy endpointMajor adverse eventsPeripheral artery diseaseAdverse event ratesCritical limb ischemiaFemoropopliteal ISRLesion revascularizationEfficacy endpointSafety endpointAdverse eventsLimb ischemiaTransluminal angioplastyArtery diseaseTCT-533 Optimal Excimer Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis. Does debulking matter?
Jayasuriya S, Mena C. TCT-533 Optimal Excimer Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis. Does debulking matter? Journal Of The American College Of Cardiology 2014, 64: b156. DOI: 10.1016/j.jacc.2014.07.592.Peer-Reviewed Original ResearchTCT-531 EXCITE ISR: A Prospective, Randomized Controlled Trial of Excimer Laser Atherectomy vs Balloon Angioplasty for the Treatment of Femoropopliteal In-Stent Restenosis
Dippel E, Makam P, Kovach R, George J, Patlola R, Metzger D, Mena C, Soukas P, Colon-Hernadez P, Stark M, Walker C. TCT-531 EXCITE ISR: A Prospective, Randomized Controlled Trial of Excimer Laser Atherectomy vs Balloon Angioplasty for the Treatment of Femoropopliteal In-Stent Restenosis. Journal Of The American College Of Cardiology 2014, 64: b155. DOI: 10.1016/j.jacc.2014.07.590.Peer-Reviewed Original ResearchRole of laser atherectomy for the management of in-stent restenosis in the peripheral arteries.
Jayasuriya S, Ward C, Mena-Hurtado C. Role of laser atherectomy for the management of in-stent restenosis in the peripheral arteries. The Journal Of Cardiovascular Surgery 2014, 55: 339-45. PMID: 24755702.Peer-Reviewed Original ResearchConceptsStent restenosisPeripheral arteriesLaser atherectomyPeripheral vascular diseasePrevalence of PADExcimer laser atherectomySurgical revascularizationClinical improvementEndovascular treatmentEndovascular techniquesPeripheral lesionsVascular diseaseChronic diseasesLower extremitiesEndovascular specialistsPopulation agesRestenosisRevascularizationAtherectomyArteryTreatmentDiseaseLesionsPrevalenceExtremities